Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: January 27, 2005
Reporting Period: Fourth quarter and full-year 2004
This filing serves to announce the issuance of a press release detailing financial results for the fourth quarter and full year of 2004. The specific financial data is contained within the press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2), which are incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are reported in the referenced press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) rather than within the body of this 8-K form.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text provided. It directs investors to the attached press release for the comparison of fourth quarter and full-year 2004 results against prior periods.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of financial results but does not contain direct management commentary, forward-looking guidance, or specific risk factors in the text provided.
Unusual Items: No unusual items are described in the filing text; all operational details are deferred to the exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2004 revenue and earnings figures.
- Examine Exhibit 99.2 for supplemental data not included in the main press release.
- Verify year-over-year growth rates and margin trends in the referenced exhibits.
- Check the press release for any updated forward-looking guidance or strategic shifts.